Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 5/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20141257 | 0.84 | CYP4F2 (0.40) | ALDH1A1LMNACYP4F2CYP4A11THRB | |
| SCHEMBL7236425 | 0.82 | LMNA (0.40) | ALDH1A1LMNACYP4F2CYP4A11THRB | |
| SCHEMBL5352192 | 0.82 | MEN1 (0.39) | ALDH1A1LMNACYP4F2CYP4A11THRB | |
| SCHEMBL6936029 | 0.81 | LMNA (0.39) | ALDH1A1LMNACYP4F2CYP4A11THRB | |
| SCHEMBL5353749 | 0.81 | LMNA (0.39) | ALDH1A1LMNACYP4F2CYP4A11THRB | |
| SCHEMBL14639270 | 0.80 | CYP4F2 (0.39) | ALDH1A1LMNACYP4F2CYP4A11THRB | |
| SCHEMBL7225893 | 0.79 | LMNA (0.37) | ALDH1A1LMNACYP4F2CYP4A11THRB | |
| SCHEMBL6067712 | 0.79 | CYP4F2 (0.45) | ALDH1A1LMNACYP4F2CYP4A11THRB | |
| SCHEMBL4646581 | 0.79 | CYP4F2 (0.62) | ALDH1A1LMNACYP4F2CYP4A11THRB | |
| SCHEMBL7225770 | 0.78 | LMNA (0.36) | ALDH1A1LMNACYP4F2CYP4A11THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1960411-B1 | HALOGEN SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2016-08-31 | — | — | EP | disclosed |
| US-9163046-B2 | Process for producing substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-10-20 | — | — | US | disclosed |
| US-8877881-B2 | Catalyst compounds and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-11-04 | — | — | US | disclosed |
| US-8557936-B2 | Catalyst compounds and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-10-15 | — | — | US | disclosed |
| US-8546501-B2 | Catalyst compounds and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-10-01 | — | — | US | disclosed |
| US-8546595-B2 | Halogen substituted heteroatom-containing metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-10-01 | — | — | US | disclosed |
| US-8541521-B2 | Catalyst compounds and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-09-24 | — | — | US | disclosed |
| US-8541522-B2 | Catalyst compounds and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-09-24 | — | — | US | disclosed |
| US-8530593-B2 | Catalyst compounds and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-09-10 | — | — | US | disclosed |
| WO-2013077943-A1 | CATALYST COMPOUNDS AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-05-30 | — | — | WO | disclosed |
| WO-2006009942-A1 | POLYMERIZATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-01-26 | — | — | WO | disclosed |
| WO-2006009980-A2 | OLEFIN POLYMERISATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-01-26 | — | — | WO | disclosed |
| WO-2006002132-A2 | OLEFIN POLYMERIZATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-01-05 | — | — | WO | disclosed |
| WO-2005118605-A1 | TRANSITION METAL COMPOUNDS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS, INC. (US) | 2005-12-15 | — | — | WO | disclosed |
| US-20050261449-A1 | Heterocyclic substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENT INC. | 2005-11-24 | — | — | US | disclosed |
| WO-2005105864-A1 | HETEROCYCLIC SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-11-10 | — | — | WO | disclosed |
| WO-2005095469-A1 | CATALYST COMPOSITION AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-10-13 | — | — | WO | disclosed |
| US-20050209420-A1 | Catalyst composition and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-09-22 | — | — | US | disclosed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | disclosed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209420-A1 | Catalyst composition and use thereof | DGAT1, DGAT2, ALOX5 | ALDH1A1 2505/4885LMNA 4044/4885CYP4F2 1515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.